Kewaunee Scientific Corporation KEQU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 66.32M | 71.40M | 69.40M | 70.10M | 71.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.32M | 71.40M | 69.40M | 70.10M | 71.10M |
| Cost of Revenue | 46.68M | 50.16M | 50.85M | 50.38M | 50.17M |
| Gross Profit | 19.64M | 21.25M | 18.55M | 19.72M | 20.93M |
| SG&A Expenses | 16.48M | 16.03M | 15.96M | 15.61M | 16.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.16M | 66.18M | 66.82M | 65.99M | 66.29M |
| Operating Income | 3.16M | 5.22M | 2.58M | 4.11M | 4.81M |
| Income Before Tax | 2.56M | 4.76M | 1.60M | 3.45M | 3.92M |
| Income Tax Expenses | 717.00K | 1.06M | 528.00K | 915.00K | 761.00K |
| Earnings from Continuing Operations | 1.84M | 3.69M | 1.08M | 2.54M | 3.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -137.00K | -304.00K | -384.00K | -93.00K | -66.00K |
| Net Income | 1.71M | 3.39M | 692.00K | 2.45M | 3.09M |
| EBIT | 3.16M | 5.22M | 2.58M | 4.11M | 4.81M |
| EBITDA | 4.75M | 6.77M | 4.18M | 5.69M | 6.36M |
| EPS Basic | 0.59 | 1.18 | 0.24 | 0.85 | 1.08 |
| Normalized Basic EPS | 0.51 | 0.93 | 0.22 | 0.72 | 0.84 |
| EPS Diluted | 0.58 | 1.13 | 0.23 | 0.82 | 1.04 |
| Normalized Diluted EPS | 0.50 | 0.89 | 0.21 | 0.69 | 0.80 |
| Average Basic Shares Outstanding | 2.88M | 2.87M | 2.87M | 2.87M | 2.85M |
| Average Diluted Shares Outstanding | 2.92M | 3.00M | 2.98M | 2.99M | 2.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |